Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 8;29(1):18-26.
doi: 10.1016/j.cmet.2018.10.012. Epub 2018 Nov 15.

Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?

Affiliations
Review

Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?

Mark A Febbraio et al. Cell Metab. .

Abstract

Hepatocellular carcinoma (HCC) is one of the most fatal and fastest-growing cancers. Recently, non-alcoholic steatohepatitis (NASH) has been recognized as a major HCC catalyst. However, it is difficult to decipher the molecular mechanisms underlying the pathogenesis of NASH and understand how it progresses to HCC by studying humans. Progress in this field depends on the availability of reliable preclinical models amenable to genetic and functional analyses and exhibiting robust NASH-to-HCC progression. Although numerous mouse models of NASH have been described, many do not faithfully mimic the human disease and few reliably progress to HCC. Here, we review current literature on the molecular etiology of NASH-related HCC and critically evaluate existing mouse models and their suitability for studying this malignancy. We also compare human transcriptomic and histopathological profiles with data from MUP-uPA mice, a reliable model of NASH-driven HCC that has been useful for evaluation of HCC-targeting immunotherapies.

Keywords: RNA-seq; fatty liver; hepatocellular carcinoma; mouse models; non-alcoholic steatohepatitis; obesity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Histological and transcriptomic alignment between the MUP-uPA mouse model and human NASH.
(A) Histological comparison of MUP-uPA mice and human NASH; data previously published (Nakagawa et al., 2014). (B) RNA-Seq data from human NASH patients and normal individuals (left) and MUP-uPA mice fed either HFD or normal chow (right). All terms are enriched with a p < 0.05, the color coding represents the p-value for enrichments calculated for the MUP-uPA+HFD mice, the darker red the more significant, and the size of the nodes represents the p-value for enrichments calculated for the human data (all nodes that are only enriched for the human data are light red, all nodes that are only enriched for MUP-uPA are small). (C) Gene alignment between our current data set of NASH patients (n = 3) compared with four other publicly available data sets.

References

    1. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, and Angulo P (2005). The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113–121. - PubMed
    1. Affo S, Yu LX, and Schwabe RF (2017). The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annu Rev Pathol 12, 153–186. - PMC - PubMed
    1. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, et al. (2013). Signatures of mutational processes in human cancer. Nature 500, 415–421. - PMC - PubMed
    1. Alkreathy HM, Khan RA, Khan MR, and Sahreen S (2014). CCl4 induced genotoxicity and DNA oxidative damages in rats: hepatoprotective effect of Sonchus arvensis. BMC complementary and alternative medicine 14, 452. - PMC - PubMed
    1. Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, Kumar DP, Daita K, Min HK, Mirshahi F, et al. (2016). A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol 65, 579–588. - PMC - PubMed

Publication types